Free Trial

Molina Healthcare, Inc (NYSE:MOH) Shares Acquired by Wealth Enhancement Advisory Services LLC

Molina Healthcare logo with Medical background

Wealth Enhancement Advisory Services LLC grew its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 82.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,635 shares of the company's stock after acquiring an additional 7,051 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in Molina Healthcare were worth $5,150,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also modified their holdings of MOH. Rothschild Investment LLC increased its position in Molina Healthcare by 126.3% in the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after purchasing an additional 48 shares during the last quarter. Colonial Trust Co SC increased its holdings in shares of Molina Healthcare by 930.0% in the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after buying an additional 93 shares during the last quarter. Hurley Capital LLC bought a new stake in shares of Molina Healthcare in the 4th quarter worth about $55,000. EverSource Wealth Advisors LLC raised its position in shares of Molina Healthcare by 81.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after buying an additional 88 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. lifted its holdings in shares of Molina Healthcare by 337.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock valued at $58,000 after acquiring an additional 155 shares during the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare Stock Up 1.9%

Shares of MOH stock traded up $5.49 on Friday, hitting $296.55. The stock had a trading volume of 640,870 shares, compared to its average volume of 692,487. Molina Healthcare, Inc has a one year low of $262.32 and a one year high of $365.23. The business has a 50 day moving average price of $307.51 and a 200 day moving average price of $306.62. The company has a market cap of $16.07 billion, a PE ratio of 14.32, a P/E/G ratio of 0.98 and a beta of 0.56. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.87.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The firm had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. During the same quarter in the prior year, the company earned $5.73 EPS. The company's revenue was up 12.2% compared to the same quarter last year. Research analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on MOH shares. Robert W. Baird reissued a "neutral" rating and set a $375.00 price objective (up from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and increased their price target for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. Mizuho lifted their price objective on shares of Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Sanford C. Bernstein initiated coverage on shares of Molina Healthcare in a research report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price objective on the stock. Finally, Baird R W cut shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Nine equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $364.21.

Read Our Latest Report on MOH

Insider Activity

In other news, Director Richard M. Schapiro sold 669 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the transaction, the director now owns 11,244 shares of the company's stock, valued at $3,603,702. The trade was a 5.62% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the sale, the chief executive officer now directly owns 257,715 shares of the company's stock, valued at $82,484,262.90. The trade was a 25.35% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.10% of the company's stock.

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

See Also

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines